By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The Irish biotech and pharmaceutical services firm Icon and Proteome Sciences have agreed to collaborate to offer a biomarker discovery solution to assess new candidate drugs, Icon said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.
In Science this week: convergent evolution in bird hemoglobin, and more.
The Wall Street Journal speaks with patients affected by questionable test results from Theranos.
Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.